H.R. 6624

119th CongressReported

Biological Intellectual Property Protection Act of 2025

Biological Intellectual Property Protection Act of 2025

Sponsored by Warren Davidson (Republican-OH-8)

Foreign Affairs & Diplomacy Foreign Assistance & Diplomacy Intellectual Property

Cosponsors

11

Actions

5

Roll calls

0

Amendments

0

Related bills

1

Actions

Apr 22, 2026 · House committee actions

Committee Consideration and Mark-up Session Held

Apr 22, 2026 · House committee actions

Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 30 - 14.

Dec 11, 2025 · Library of Congress

Introduced in House

Dec 11, 2025 · Library of Congress

Introduced in House

Dec 11, 2025 · House floor actions

Referred to the House Committee on Foreign Affairs.

Latest activity

Activity

July 2026

Lobbying reported · Amgen · Jul 20

Amgen reported 2nd Quarter (Apr 1 - June 30) lobbying for Amgen — $2,440,000

Lobbying reported · Pharmaceutical Research and Manufacturers of America (PhRMA) · Jul 20

Pharmaceutical Research and Manufacturers of America (PhRMA) reported 2nd Quarter (Apr 1 - June 30) lobbying for Pharmaceutical Research and Manufacturers of America (PhRMA) — $7,360,000

Lobbying reported · Demand Progress Action · Jul 20

Demand Progress Action reported 2nd Quarter (Apr 1 - June 30) lobbying for Demand Progress Action — $70,000

Lobbying reported · Fdd Action · Jul 20

Fdd Action reported 2nd Quarter (Apr 1 - June 30) lobbying for Fdd Action — $240,000

BillsH.Con.Res. 38 H.Con.Res. 40 H.Con.Res. 75 H.Con.Res. 84 H.Con.Res. 86 H.J.Res. 176 H.J.Res. 200 H.R. 36 H.R. 425 H.R. 881 H.R. 1048 H.R. 1422 H.R. 1736 H.R. 1800 H.R. 2158 H.R. 2212 H.R. 2505 H.R. 2658 H.R. 2683 H.R. 3307 H.R. 3447 H.R. 3563 H.R. 4397 H.R. 4505 H.R. 4531 H.R. 4920 H.R. 4930 H.R. 5490 H.R. 5853 H.R. 6058 H.R. 6106 H.R. 6230 H.R. 6322 H.R. 6331 H.R. 6469 H.R. 6624 H.R. 6875 H.R. 6988 H.R. 6996 H.R. 7003 H.R. 7037 H.R. 7126 H.R. 7146 H.R. 7178 H.R. 7184 H.R. 7273 H.R. 7380 H.R. 7540 H.R. 7552 H.R. 7567 H.R. 7622 H.R. 7625 H.R. 7668 H.R. 7924 H.R. 8019 H.R. 8022 H.R. 8036 H.R. 8069 H.R. 8106 H.R. 8168 H.R. 8169 H.R. 8170 H.R. 8177 H.R. 8202 H.R. 8283 H.R. 8284 H.R. 8433 H.R. 8516 H.R. 8558 H.R. 8559 H.R. 8595 H.R. 8649 H.R. 8665 H.R. 8693 H.R. 8700 H.R. 8718 H.R. 8730 H.R. 8787 H.R. 8800 H.R. 8901 H.R. 9020 H.R. 9087 H.R. 9102 H.R. 9129 H.R. 9147 H.R. 9227 H.R. 9232 H.R. 9256 H.R. 9322 H.R. 9366 H.R. 9450 H.R. 9451 H.R. 9495 H.R. 9550 H.R. 9592 H.Res. 564 H.Res. 1246 H.Res. 1379 S. 63 S. 556 S. 933 S. 1296 S. 1473 S. 1705 S. 1744 S. 1889 S. 1962 S. 2132 S. 2293 S. 2677 S. 2904 S. 3050 S. 3172 S. 3181 S. 3249 S. 3360 S. 3404 S. 3452 S. 3496 S. 3519 S. 3855 S. 3900 S. 4192 S. 4219 S. 4281 S. 4296 S. 4379 S. 4380 S. 4392 S. 4423 S. 4424 S. 4429 S. 4443 S. 4446 S. 4456 S. 4525 S. 4544 S. 4565 S. 4570 S. 4600 S. 4665 S. 4711 S. 4723 S. 4784 S. 4826 S. 4835 S. 4853 S.J.Res. 114 S.J.Res. 123 S.J.Res. 163 S.J.Res. 184 S.J.Res. 185 S.Res. 236

Lobbying reported · Lenovo (united States) · Jul 20

Lenovo (united States) reported 2nd Quarter (Apr 1 - June 30) lobbying for Lenovo (united States) — $570,000

Lobbying reported · Glaxosmithkline · Jul 16

Glaxosmithkline reported 2nd Quarter (Apr 1 - June 30) lobbying for Glaxosmithkline — $890,000

Lobbying reported · Ipolicy Solutions · Jul 16

Ipolicy Solutions reported 2nd Quarter (Apr 1 - June 30) lobbying for Twist Bioscience — $82,500

BillsH.R. 6624 S. 3452 S. 3741

You’re all caught up.